An ultralate female growing teratoma syndrome: 19 years after aggressive treatment for advanced ovarian immature teratoma
نویسندگان
چکیده
منابع مشابه
Spontaneous Growing Syndrome of an Immature Teratoma
Background: Immature teratomas of the ovary represent less than 1% of all ovarian teratomas. Growing teratoma syndrome is an increase of tumor size containing a mature teratoma component, during or after chemotherapy for
متن کاملGrowing Teratoma Syndrome Secondary to Ovarian Giant Immature Teratoma in an Adolescent Girl
Growing teratoma syndrome (GTS) is a rare clinical entity first described by Logothetis et al in 1982. Although it is unusual for GTS to be located in the ovary, this report is of a case of an adolescent girl who underwent a complete surgical resection of the mass. Histopathology confirmed only an immature teratoma had originated from the ovary and so she received adjuvant chemotherapy with ble...
متن کاملPediatric Ovarian Growing Teratoma Syndrome
Ovarian immature teratoma is a germ cell tumor that comprises less than 1% of ovarian cancers and is treated with surgical debulking and chemotherapy depending on stage. Growing teratoma syndrome (GTS) is the phenomenon of the growth of mature teratoma elements with normal tumor markers during or following chemotherapy for treatment of a malignant germ cell tumor. These tumors are associated wi...
متن کاملGrowing teratoma syndrome following primary ovarian immature teratoma: two cases and review of literature
Growing Teratoma Syndrome (GTS) is defined as the occurrence of a tumor mass consisting exclusively of mature teratoma, combined with normal tumor marker levels, during or after chemotherapy in patients with Non Seminomatous Germ Cell Tumors (NSGCT). We report two cases of GTS. Case 1 is a woman with concomitant retroperitoneal mass invading the muscular layer of abdominal wall, and scattered n...
متن کاملGrowing Teratoma Syndrome
Growing teratoma syndrome (GTS) is a rare clinical entity, which presents with enlarging teratomas masses of the retroperitoneum or other locations, occurring during or after systemic chemotherapy for the treatment of nonseminomatous germ cell of the testis (NSGCT), with normalised tumour markers. Awareness of this syndrome is necessary in order to prevent unnecessary chemotherapy and allow opt...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gynecology and Minimally Invasive Therapy
سال: 2020
ISSN: 2213-3070
DOI: 10.4103/gmit.gmit_70_18